ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 58575 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 58575; 2) Community: the network communities that were significantly associated with the response to NSC 58575; 3) Molecule: the relationships between components within communities and NSC 58575; 4) MDR: the compounds that were significantly associated with the NSC 58575.

NSC Compound Enrichment Correlation
NSC 756375 GW811761X 0.0434721470609156 -0.091607038
NSC 761822 (Z)-3-((1-(4-fluorophenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.0434721470609156 0.24711601
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0434721470609156 0.22376743
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.0434721470609156 0.25971753
NSC 85561 3-hydroxy-4-((1-hydroxynaphthalen-2-yl)diazenyl)-7-nitronaphthalene-1-sulfonic acid, sodium sallt 0.0434721470609156 0.37621197
NSC 90736 Null 0.0434721470609156 0.32940762
NSC 93819 Depakine 0.0434721470609156 -0.063144159
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.0446159312763229 0.2579125
NSC 319440 Null 0.0446159312763229 -0.28370938
NSC 373814 Null 0.0446159312763229 0.62249377
Total:99  Current:81    [First] [Prev] [Next] [Last]